Clinical Trial Update: BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update announcing a Phase 2/3 study of BAT1308 in combination with platinum-based chemotherapy, with or without bevacizumab, for PD-L1-positive (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• BAT1308 (BAT1308)
• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Cervical Cancer | Phase 2, Phase 3 | Status: RECRUITING